Skip to content

The Ocular Coil Drug delivery Comfort (OCDC) trial

The Ocular Coil Drug delivery Comfort (OCDC) trial - OCDC

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON47468
Enrollment
40
Registered
2016-07-20
Start date
2018-06-27
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

niet van toepassing

Interventions

None listed

Sponsors

Oogheelkunde
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * Age between 18 and 75 years old * Informed and having given informed consent * Willing and able to comply with scheduled visits and other study procedures * If wearing contact lenses, willing to replace them for glasses for the duration of the study

Exclusion criteria

Exclusion criteria: * Subjects with a history of eye disease * Subjects using eye drops (during the study). * Subjects with an Oriental/Asian lid crease, because of their narrow fornix. * Subjects who do not speak and/or write Dutch properly. * Subjects with a history of serious adverse reaction or hypersensitivity - Subjects with hay fever * Women who are pregnant or nursing their child, or have the intention to become pregnant during the course of the study.

Design outcomes

Primary

MeasureTime frame
The primary objective is the evaluation of the safety of the ocular coil.

Secondary

MeasureTime frame
Secondary objectives are coil retention (duration), subject comfort (tolerance) and incidence of adverse effects and complications.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)